Michaela Dinboeck is Head of Patient Engagement at Novartis. She has strong experience in progressive country, regional and global business leadership and Board Membership in the Pharmaceutical Industry, Medical Devices, Universities and Multi-Stakeholder Alliances. Her business profile is uniquely combined with the development of thought leadership in the evolving area of Patient Engagement. During her talk, Michaela is going to share interesting insights about the pivotal role of patient engagement along the whole process of drug discovery & development and how it affects pharmaceutical decision making. She will explain the practices used by the pharma industry in order to involve the patients’ voice in product development and how this leads to added-value medicine.